1

Identity

Novartis Farmaceutica, S.A.

A08011074

€717M

Amount awarded, solo awards 2016–2026

Amount awarded by year
YearAmountDistribution
2026*€96.7M
2025€201.0M
2024€126.4M
+ regional platforms
2023€85.1M
2022€29.6M
2021€73.7M
2020€34.3M
2019€63.5M
2018€6.5M
2017€0.3M
2016€<0.1M
*2026: data to 31 October · 158 contracts in 2026 · Since 2024 this also includes data from regional platforms. · Solo awards, excluding JVs · Framework agreements at €0 · €M
1,286
Contracts (lots)
across 806 tenders
51
Buyers
96%
Single bidder
9
Awards in UTEs
not in the total

In figures

Volume

Between 2016 and 2026 it won 1,286 contracts worth €717M on its own, with 51 buyers. Its 9 joint-venture (UTE) contracts are shown separately.

Price

It has fewer than 3 comparable awards, too few to compute its median discount.

Competition

Since 2024, <1% of its comparable value was won with a discount and against other bidders. It was the only bidder in 96% of its contracts (2016–2026).

Renewals

94 contracts (€50.5M) come up for tender again in the next 24 months.

A UTE is a temporary joint venture: the contract is awarded to the UTE and each partner's share is not published. That is why these contracts are not added to Novartis Farmaceutica, S.A.'s total, and under «Show UTEs» the amounts are the full value of each contract (100%), not Novartis Farmaceutica, S.A.'s share.

Data up to 31 October 2026 · updated on 12 November 2026 · Source: official data, national and regional coverage

2

Its discounts

The discount at which it wins contested contracts, year by year.

Only 1 contested award can be compared — not enough to read how it prices. Of its 1,286 contracts, 848 are call-offs under framework agreements and 226 were awarded without competition (negotiated without publicity or direct award).

Framework call-offs 848 · Single bidder 29 · Non-competitive procedure 226 · No comparable budget 182 · Contested, comparable 1

Where it wins, and at what discount

In the report · these discounts, one by one

Each dot on the chart is an award. The report lists them all and groups them by buyer and by sector, next to the discounts of other companies with the same buyers.

Request the report →

Full list: date, buyer, amount, budget, discount, bidders and a link to the official publication.

3

How it wins

Whether it wins with or without competition.

Competition and pricing

93% of the comparable value since 2024 (€871k of €936k) was won at the tender price and without other bidders. Only €64.0k (7%) was awarded with a discount and without other bidders.

With a discount
7%
single bidder · 2 · €64.0k
<1%
multiple bidders · 1 · €413
At the tender price
93%
single bidder · 11 · €871k
0%
multiple bidders · 0

Comparable: 14 awards with a published budget and bidder count (€936k of €424M awarded since 2024). Percentages of value; the figure next to «bidders» is the number of awards. Source: official data, national and regional coverage.

Award procedure

Between 2016 and 2026, 71.8% of the value was awarded through negotiated without publicity procedure (51.2% of contracts); followed by Based on a framework agreement (14.1%) and Other (7.6%).

Based on a framework agreement · 14.1%
Negotiated without publicity · 71.8%
Open
Restricted
Based on a framework agreement
Negotiated without publicity
Other
4

Upcoming tenders and main buyers

When its contracts come back and who it sells to.

When its contracts come back

In the next 24 months 94 of its contracts come up for tender again, worth €50.5M.

Expected endBuyerValue
2026Gerencia de Atención Sanitaria del Instituto Nacional de Gestión Sanitaria en Ceuta€229k
2026Hospital Universitario de Fuenlabrada€194k
2026Hospital Universitario Fundación Alcorcón€183k
2026Gerencia de Servicio Sanitarios de Fuerteventura€7.08k
2026Gerencia de Servicio Sanitarios de Fuerteventura€1.42k

and 89 more in the next 24 months · the report includes them all

Expected end year from the published duration (no extensions). The report includes the month and the discount it won each one at.

Who they sell to
BuyerContractsValue, €Period
Gerencia de Servicio Sanitarios de Fuerteventura800195 M2018–2026
Servicio Andaluz de Salud51105 M2024–2026
OSAKIDETZA - Servicio Vasco de Salud -Director General2550 M2024–2026
Gerencia Regional de Salud de Castilla y León1348 M2018–2026
Dirección General de Planificación Económica3745 M2018–2026

and 46 more buyers

Sector activity
Top CPV codes — the EU classification system that identifies the type of works, services or supplies covered by each contract.

Between 2016 and 2026, 100.0% of the value it won on its own is in Medical & pharmaceuticals (CPV 33, 1,262 contracts).

Medical & pharmaceuticals
100.0%1262 contracts
Petroleum & energy
<0.1%1 contract
5

Recent awards

The evidence behind every insight in the report.

Latest 5 completed contracts (of 389)
Contracts whose expected completion date has passed.
DateContractBuyerBiddersValue
11/09/2026Lutecio (177LU) 1000 MBQ/ml solución inyectable y para perfusión (Vipivotida Tetraxetan). "Emergenc…Servicio Cántabro de Salud1€83.4k
03/09/2026Lutecio (177LU) 1000 MBQ/ml solución inyectable y para perfusión (Vipivotida Tetraxetan). "Emergenc…Servicio Cántabro de Salud1€83.4k
29/07/2026Lutecio (177LU) 1000 MBQ/ml solución inyectable y para perfusión (Vipivotida Tetraxetan). "Emergenc…Servicio Cántabro de Salud1€83.4k
03/07/2026Suministro de medicamentos de uso humano tipo II (Exclusivos), con destino al Servicio de Farmacia …Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria1€80.4k
08/06/2026cpca 1º cbam novartis farmaceutica, s.a. exp. 578/2025 suministro medicamento exclusivos cca: +6.i+…Servicio Andaluz de Salud1€913k
Full report on Novartis Farmaceutica, S.A.
Includes: its discount by buyer and sector · winning discounts by buyer and year · how it wins with each buyer · contract renewal calendar. The complete register of its awards in the last three full calendar years and the current year to date, in Excel.
€50 + VAT · VAT is calculated at payment according to your country. You will receive it in PDF and Excel by email within one working day. Every report is reviewed by a person before it is sent to you.
Order the report